India Pharma Outlook Team | Tuesday, 09 June 2026
India gets its first AI-Powered mammography system from FUJIFILM as the healthcare technology company announced the installation of its advanced AMULET SOPHINITY digital mammography platform at NM Medical, one of India's leading diagnostic healthcare providers.
The milestone marks the first deployment of the AI-powered mammography system in the country and highlights the growing role of artificial intelligence in improving breast cancer screening, early diagnosis, and patient care.
The installation was officially announced during a special event at NM Medical, which operates more than 22 diagnostic centres across India and is backed by a multidisciplinary team of over 1,000 healthcare professionals. As India gets first AI mammography system from FUJIFILM, the move is expected to support healthcare providers in addressing the rising burden of breast cancer through advanced imaging technology and improved diagnostic accuracy.
The installation of AMULET SOPHINITY represents a significant advancement in India's diagnostic imaging landscape. Developed by FUJIFILM, the next-generation digital mammography system is designed to enhance breast cancer detection while improving the overall screening experience for patients and healthcare professionals.
The launch comes at a crucial time for India's healthcare sector. According to estimates from the Indian Council of Medical Research's National Cancer Registry Programme, breast cancer is expected to remain the most common cancer among Indian women, with more than 2.32 lakh cases projected in 2025. Early detection continues to be one of the most effective strategies for improving treatment outcomes and survival rates.
By introducing advanced AI-driven imaging technologies, FUJIFILM aims to support healthcare institutions in identifying abnormalities at earlier stages, enabling faster clinical intervention and more effective treatment planning.
Also Read: GLP-1 Side Effects: Tips for Gastrointestinal Comfort 2026 Update
One of the key highlights of the AMULET SOPHINITY platform is its integration with FUJIFILM's REiLI Medical AI technologies. These intelligent features are designed to improve image quality, optimize radiation dose management, and support healthcare professionals during screening procedures.
The system includes Intelligent Automatic Exposure Control (AEC), which helps optimize radiation dose levels based on the patient's breast composition. This feature ensures that high-quality diagnostic images can be obtained while maintaining appropriate exposure levels.
Another notable feature is Positioning MAP, which assists technologists in achieving consistent and reproducible patient positioning during mammography examinations. Accurate positioning is critical for obtaining reliable imaging results and reducing the need for repeat examinations.
The platform also incorporates AI-driven Positioning Analysis tools that provide feedback to technologists, helping them continuously improve imaging quality and maintain consistency across examinations.
In addition to its AI capabilities, the AMULET SOPHINITY system has been designed with patient comfort in mind. The technology aims to make breast cancer screening more accessible and patient-friendly, encouraging greater participation in regular screening programs.
Dr. Shilpa Lad, Consultant Breast Imaging and Interventions at NM Medical, emphasized the value of the technology in enhancing both clinical outcomes and patient experience.
According to Dr. Lad, AI-assisted positioning capabilities and comfort-focused design features help improve consistency during imaging procedures while making the screening process more comfortable for patients.
These advancements are expected to contribute to more accurate examinations and a smoother screening experience, factors that play an important role in promoting preventive healthcare practices.
The installation reflects FUJIFILM India's broader commitment to strengthening preventive healthcare infrastructure across the country. The company continues to focus on introducing advanced Japanese healthcare technologies that support early diagnosis and improved patient outcomes.
Koji Wada, Managing Director of FUJIFILM India, stated that the company remains committed to bringing Japanese precision and advanced healthcare technologies to India's healthcare ecosystem. He noted that these innovations are intended to support early diagnosis, improve accessibility, and contribute to better healthcare outcomes nationwide.
NM Medical also views the new installation as an important step in expanding its women's healthcare services.
Dr. Nilesh Shah, Chairman of NM Medical, said that the addition of AI-powered digital mammography, alongside biopsies, histopathology, and genomics capabilities, will further strengthen the organization's commitment to precision-led imaging and early diagnosis for women.
A Major Step Forward for Women's Healthcare in India
The deployment of India's first AMULET SOPHINITY system underscores the growing importance of artificial intelligence in modern healthcare. As breast cancer cases continue to rise, investments in advanced diagnostic technologies are becoming increasingly important for improving screening efficiency, diagnostic confidence, and patient outcomes.
With the introduction of AI-powered mammography at NM Medical, healthcare providers gain access to innovative tools that can help detect breast cancer earlier, improve imaging consistency, and support more informed clinical decisions. The installation also signals a broader shift toward technology-driven preventive healthcare solutions that can address some of India's most pressing healthcare challenges.
FUJIFILM India is a subsidiary of the global FUJIFILM Group and offers innovative solutions across healthcare, imaging, business innovation, and industrial sectors. The company focuses on introducing advanced Japanese technologies that improve diagnostic capabilities, healthcare accessibility, and patient outcomes across India.
NM Medical is one of India's leading diagnostic healthcare providers, operating more than 22 centres and supported by a team of over 1,000 healthcare professionals. With over three decades of experience, the organization offers comprehensive diagnostic services and is committed to delivering accurate, technology-driven healthcare solutions.
.jpg)
